|HUM-MOLGEN -> Events -> Meetings and Conferences|
|IBC's Cell-Based Assays & Screening|
|August 21, 2002|
-, Philadelphia, PA
December 4-6, 2002
At this inaugural meeting, a group of leading scientists from Merck, Johnson & Johnson, AstraZeneca, Bayer, Sugen, GlaxoSmithKline, among others, will provide their insights into the significance of cell-based assays to their research. With a Pre-Conference symposium on “Cell Culture & Analaysis,” and main conference sessions focussing on real-world case studies; novel screening platforms; cell-imaging technologies and future applications of micro- & nano-technology in cell-based assays, this 3-day event aims to share the secrets and uncover the breakthroughs in the drug discovery and development process.
|Organized by:||IBC Life Sciences|
|Invited Speakers:||Scientific Advisory Board
Lisa Minor, Ph.D., Johnson & Johnson Pharmaceuticals
Jim Inglese, Ph.D., Merck Research Laboratories
Yingfei Wei, Ph.D., Bayer Biotechnology
Patricia A. Kasila, PerkinElmer Life Sciences
|Deadline for Abstracts:||-|
|Registration:||Five Easy Ways to Register!
Phone (508) 616-5550
Fax (508) 616-5522
IBC USA Conferences, Inc.
One Research Drive
Westborough, MA 01581-5195
|Posted by:||James G. Prudhomme|